Prevena Vascular Groin Wound Study
- Conditions
- Wound InfectionPeripheral Arterial DiseaseAneurysmSurgical Wound Dehiscence
- Interventions
- Device: Dry gauze dressing careDevice: Prevena Care
- Registration Number
- NCT02581904
- Lead Sponsor
- Thomas Jefferson University
- Brief Summary
The purpose of this study is to determine if the application of a negative pressure dressing intraoperatively (Prevena; KCI, Inc) to vascular groin incisions decreases the wound complication rate in high risk patients.
- Detailed Description
The study randomizes patients (1:1) considered high risk, according to a specific set of risk factors, for wound complications into standard post-op dressings vs. Prevena vacuum dressing. The wounds will then be assessed for wound complications in the 30 days postoperatively. Wound complications include breakdown, infection and lymph leak. Patients not considered high risk will have standard post-op dressings and followed similarly to controls. The investigators will also assess economic impact of negative pressure dressing on length of stay and overall inpatient costs.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 150
- All patients undergoing a femoral incision during vascular reconstruction or repair will be considered for study
- Emergency procedure
- Unable to give informed consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Low Risk - Dry Gauze Dressing Care Dry gauze dressing care Initial dry gauze dressing will be placed sterile in the operating room and will be changed daily High Risk - Dry Gauze Dressing Care Dry gauze dressing care Initial dry gauze dressing will be placed sterile in the operating room and will be changed daily High Risk - Prevena Care Prevena Care The Prevena device is a product from KCI and is a sterile sponge that covers the closed incision. The device is placed sterile in the operating room and suction is then applied to the sponge for 5-7 days.
- Primary Outcome Measures
Name Time Method Groin Wound Complication 30 days Composite measure including wound dehiscence (skin or fascia), lymph leak (seroma or fistula), infection (deep or superficial), or hematoma
- Secondary Outcome Measures
Name Time Method Hospital Readmission 30 days Readmission for wound complication
Return to Operating Room 30 days Index Hospital Cost 30 days Hospital Length of stay 30 days
Trial Locations
- Locations (1)
Thomas Jefferson University Hospital
🇺🇸Philadelphia, Pennsylvania, United States